eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
3/2020
vol. 22
 
Share:
Send email
Share:
Original paper

Risk analysis for cardiovascular complication based on the atherogenic index of plasma of type 2 diabetes mellitus patients in Medan, Indonesia

Rina Amelia
1
,
Juliandi Harahap
1
,
Aznan Lelo
2
,
Hendri Wijaya
3
,
Novita Sari Harahap
2
,
Zulham Yamamoto
4

  1. Department of Community Medicine/Public Health, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  2. Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  3. Department of Pediatrics, Faculty of Medicine, Universitas Sumatera Utara, H. Adam Malik General Hospital, Indonesia
  4. Department of Histology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Family Medicine & Primary Care Review 2020; 22(3): 197–201
DOI: https://doi.org/10.5114/fmpcr.2020.98242
Online publish date: 2020/10/16
Article file
- 03 FM&PCR 3 20 - O - Amelia - Risk analysis - 740.pdf  [0.44 MB]
Get citation
 
PlumX metrics:
 
1. Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018; 41(12): 2669–2701.
2. Yang SH, Du Y, Li XL, et al. Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in diabetics with coronary artery disease. Am J Med Sci 2017; 354(2): 117–124.
3. Bo MS, Cheah WL, Lwin S , et al. Understanding the relationship between atherogenic index of plasma and cardiovascular disease risk factors among staff of an University in Malaysia. J Nutr Metab 2018; 2018(3): 1–6, doi: 10.1155/2018/7027624.
4. Younis NN, Soran H, Sharma R, et al. Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes. Diab Vasc Dis Res 2010; 7(4): 289–295.
5. Rabbani N, Godfrey L, Xue M, et al. Glycation of LDL by methylglyoxal increases arterial atherogenicity: a possible contributor to increased risk of cardiovascular disease in diabetes. Diabetes 2011; 60(7): 1973–1980.
6. Noviyanti F, Decroli E, Sastri S. Perbedaan Kadar LDL-kolesterol pada Pasien Diabetes Melitus Tipe 2 dengan dan tanpa Hipertensi di RS Dr. M. Djamil Padang Tahun 2011. Jurnal Kesehatan Andalas 2015; 4(2): PAGES.
7. Khazaal MS. Atherogenic Index of Plasma (AIP) as a parameter in predicting cardiovascular risk in males compared to the conventional dyslipidemic indices (cholesterol ratios). Karbala J Med 2013; 6(1): 1506–1513.
8. Li Z, Huang Q, Sun L, et al. Atherogenic index in type 2 diabetes and its relationship with chronic microvascular complications. International Journal of Endocrinology 2018; 2018(3): 1–9, doi: 10.1155/2018/1765835.
9. Hartopo AB, Arso IA, Setianto BY. Low plasma atherogenic index associated with poor prognosis in hospitalized patients with acute myocardial infarction. Acta Medica Indonesiana 2016; 48(2): 106–113.
10. Momin AA, Bankar MP, Bhoite GM. Glycosylated hemoglobin (HbA1C): association with dyslipidemia and predictor of cardiovascular diseases in type 2 diabetes mellitus patients. Int J Health Sci Res 2013; 3(8): 40–46.
11. Ni W, Zhou Z, Liu T, et al. Gender-and lesion number-dependent difference in “atherogenic index of plasma” in Chinese people with coronary heart disease. Scientific Reports 2017; 7(1): 1–6, doi: 10.1038/s41598-017-13267-6.
12. Aip Calculator [online]. Available in URL: http://www.biomed.cas.cz/fgu/aip/kalkulator.php.
13. Kamble PM, Choudhari SC, Yadav AS. Study of lipid profile, oxidative stress, and antioxidant status, in type-2 diabetes mellitus. Walawalkar International Medical Journal 2015; 2(21): 28–36.
14. Anjum M, Uddin MS, Tamanna NA, et al. Evaluation of lipid profile pattern and atherogenic index of plasma (AIP) having type-2 diabetes mellitus in Bangladesh. International Journal of Research in Medical Sciences 2018; 6(3): 776, doi: 10.18203/2320-6012.ijrms20180595.
15. Amelia R, Damanik HA, Lindarto D, et al. The correlation between the level of HbA1c with total serum cholesterol of uncontrolled Type 2 Diabetes Mellitus patients in Binjai, Sumatera Utara. Adv Sci Lett 2017; 23(4): 3610–3613.
16. Amelia R, Harahap J, Wahyuni AS, et al. Health status of elderly based on daily activities living, cholesterol and uric acid profile in Medan city. InIOP Conference Series: Earth and Environmental Science 2018; 125(1): 012175.
17. Ozder A. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Lipids Health Dis 2014; 13: 183, doi: 10.1186/1476-511X-13-183.
18. Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, et al. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes 2014; 5(4): 444–470.
19. Cefalu WT. The journal of clinical and applied research and education. Diabetes Care 2017; 40(Suppl.): S1–S2.
20. Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007; 115(1): 114–126.
21. Juárez-Pérez CA, Aguilar-Madrid G, Haro-García LC, et al. Increased cardiovascular risk using atherogenic index measurement among healthcare workers. Arch Med Res 2015; 46(3): 233–239.
22. Nimmanapalli HD, Kasi AD, Devapatla PK, et al. Lipid ratios, atherogenic coefficient and atherogenic index of plasma as parameters in assessing cardiovascular risk in type 2 diabetes mellitus. Int J Res Med Sci 2016; 4(7): 2863–2869.
23. Cai G, Shi G, Xue S, et al. The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine (Baltimore) 2017; 96(37): e8058, doi: 10.1097/MD.0000000000008058.
24. Li Z, Huang Q, Sun L, et al. Atherogenic index in type 2 diabetes and its relationship with chronic microvascular complications. International journal of endocrinology. 2018;2018. To samo co 8.
25. Arnett DK, Blumenthal RS, Albert MA, et al. ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. JACC 2019; 74(10): e177–e232.
26. Bertoluci MC, Rocha VZ. Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr 2017; 9(1): 25, doi: 10.1186/s13098-017-0225-1.
27. Zhang H, Qin L, Sheng CS, et al. ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk. BMJ Open Diabetes Res Care 2020; 8(1): e000810, doi: 10.1136/bmjdrc-2019-000810.
28. Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, et al. Atherogenic Index of Plasma (AIP): a marker of cardiovascular. Med J Islam Repub Iran 2015; 29: 240.
29. Nansseu JR, Moor VJ, Nouaga ME, et al. Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women. Lipids Health Dis 2016; 15: 49, doi: 10.1186/s12944-016-0222-7.
30. Di CH, Rui DU, Yan WX, et al. Serum uric acid is associated with the predicted risk of prevalent cardiovascular disease in a community-dwelling population without diabetes. Biomed Environ Sci 2018; 31(2): 106–114.
Copyright: © 2020 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.